SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-17-000480
Filing Date
2017-03-02
Accepted
2017-03-02 16:07:10
Documents
1
Period of Report
2017-02-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT mclaughlin_f4.html 4  
1 OWNERSHIP DOCUMENT mclaughlin_f4.xml 4 4960
  Complete submission text file 0001683168-17-000480.txt   6439
Mailing Address OCULUS INNOVATIVE SCIENCES, INC. 1129 N. MCDOWELL BLVD. PETALUMA CA 94954
Business Address
MCLAUGHLIN JOHN (Reporting) CIK: 0001203240 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33216 | Film No.: 17658769

Mailing Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954
Business Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954 707-283-0550
Sonoma Pharmaceuticals, Inc. (Issuer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations